The prevalence and predictors of using herbal medicines among Iranian cancer patients.

Autor: Bazrafshani MS; Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran., Khandani BK; Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: B_kalantari@kmu.ac.ir., Pardakhty A; Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran., Tajadini H; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran., Pour Afshar RM; Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran., Moazed V; Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran., Nemati A; Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran., Nasiri N; Department of Public Health, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran., Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Publikováno v: Complementary therapies in clinical practice [Complement Ther Clin Pract] 2019 May; Vol. 35, pp. 368-373. Date of Electronic Publication: 2019 Mar 13.